Skip to main content
. 2017 Jun 1;11(6):VC05–VC08. doi: 10.7860/JCDR/2017/25801.10011

[Table/Fig-5]:

Prevalence of metabolic syndrome as per psychotropic drugs received.

Treatment received Total No. of Patients Metabolic Syndrome p-value
Absent Present
FGA’s 12 9 (75%) 3 (25%) p<0.05*
SGA’s 22 8 (36.36%) 14 (63.64%)
Mood Stabilizers 21 16 (76.19%) 5 (23.81%)
Antidepressants 17 15 (88.24%) 2 (11.76%)
Multiple drugs 54 27 (50%) 27 (50%)

FGA’s = First Generation Antipsychotics SGA’s = Second Generation Antipsychotics

*

Chi-square test showing difference among groups.